| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Donald J Hayden Jr. last filed a Form 4 in May 2020, as Director at INSM. The filings on record cover 3 companies. Donald J Hayden Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 62,197 shares of INSM. The INSM filings lean toward selling, a net 106,286 shares.
Donald J Hayden Jr. has 34 Form 4 filings on record from September 2015 to May 2020, across 3 companies: Director at Regenxbio (RGNX), 2015–2020; Director at Insmed (INSM), 2015–2019; Director at Amicus Therapeutics (FOLD), 2017–2018.
The 66 reported transactions were 29 open-market sales, 23 option exercises, 8 option or other derivative awards and 5 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 22 sales worth about $12.7M.
The largest open-market sale was 30,000 shares of RGNX at an average $45.60 on January 14, 2020, about $1.4M.
Shares as reported in the last Form 4 for each company; the most recent is from May 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2020 | RGNX Regenxbio Inc. | Director | Sale+OE | 24,800 | $50.11 | $1,242,728.00 | - | |
| Feb 5, 2020 | RGNX Regenxbio Inc. | Director | Sale+OE | 2,000 | $50.00 | $100,000.00 | - | |
| Jan 17, 2020 | RGNX Regenxbio Inc. | Director | Sale+OE | 3,200 | $50.01 | $160,032.00 | - | |
| Jan 14, 2020 | RGNX Regenxbio Inc. | Director | Sale+OE | 30,000 | $45.60 | $1,368,000.00 | - | |
| Apr 9, 2019 | INSM Insmed Inc | Director | Sale+OE | 6,286 | $32.99 | $207,375.14 | -9.2% | |
| Feb 22, 2019 | INSM Insmed Inc | Director | Sale+OE | 14,900 | $28.08 | $418,392.00 | -19.3% | |
| Feb 15, 2019 | INSM Insmed Inc | Director | Sale+OE | 100 | $27.90 | $2,790.00 | -0.2% | |
| Jun 5, 2018 | RGNX Regenxbio Inc. | Director | Sale+OE | 15,000 | $55.01 | $825,149.00 | - | |
| May 15, 2018 | RGNX Regenxbio Inc. | Director | Sale+OE | 15,000 | $50.05 | $750,796.94 | - | |
| May 9, 2018 | RGNX Regenxbio Inc. | Director | Sale+OE | 15,000 | $45.00 | $675,000.00 | - |